Immediate Impact

14 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
2022 Standout
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls
2021 Standout
2 intermediate papers

Works of C Granata being referenced

Spine surgery in spinal muscular atrophy: Long-term results
1993
Spinal Muscular Atrophy: Natural History and Orthopaedic Treatment of Scoliosis
1989
and 1 more

Author Peers

Author Last Decade Papers Cites
C Granata 280 240 312 26 647
I. Hodgkinson 164 162 228 19 739
Bakri Elsheikh 476 293 335 41 707
Simona Lucibello 284 221 270 28 580
Karlien Mul 168 100 492 53 737
Fay‐Lynn Asselman 501 325 240 36 616
Mike Pike 118 95 468 11 683
Susan Riley 589 408 310 16 737
Jwalant Mehta 81 294 176 32 536
France W. Fung 214 129 154 32 682
Stephanie Hyde 125 58 363 19 736

All Works

Loading papers...

Rankless by CCL
2026